List: Causes of Hyper/Hypokalaemia
TL;DR
For MRCP Part 1, electrolyte disorders are tested repeatedly because they integrate renal physiology, endocrinology, pharmacology and emergency medicine. List: Causes of Hyper/Hypokalemia is a favourite revision topic, with exam questions often asking candidates to identify the most likely underlying mechanism rather than simply recalling potassium values. This guide provides the highest-yield causes, common examination traps, a short clinical case and practical revision tips.
Why this matters
Hyperkalaemia and hypokalaemia appear across multiple MRCP specialties:
Nephrology
Cardiology
Endocrinology
Emergency medicine
Intensive care
Clinical pharmacology
Candidates should rapidly distinguish:
Reduced intake versus increased loss
Renal versus extrarenal causes
Transcellular shifts versus true potassium depletion
Genuine hyperkalaemia versus pseudohyperkalaemia
Core sections
Potassium physiology in one minute
Approximately 98% of total body potassium is intracellular, with only around 2% present extracellularly.
Normal serum potassium:
3.5–5.0 mmol/L
Potassium homeostasis depends on:
Renal excretion
Aldosterone
Insulin
β2-adrenergic stimulation
Acid-base balance
Cellular integrity
Remember:
Serum potassium may be normal despite severe total body depletion.
The 10 highest-yield causes of hyperkalaemia
Cause | Mechanism | High-yield MRCP clue |
Acute kidney injury | Reduced renal excretion | Rising creatinine |
Chronic kidney disease | Reduced potassium clearance | Advanced CKD |
ACE inhibitors/ARBs | Reduced aldosterone | Hypertension treatment |
Potassium-sparing diuretics | Reduced potassium secretion | Spironolactone, eplerenone, amiloride |
Addison's disease | Aldosterone deficiency | Hyperpigmentation, hypotension |
Metabolic acidosis | Potassium shifts extracellularly | DKA, renal failure |
Tissue breakdown | Potassium release | Rhabdomyolysis, burns, tumour lysis |
Insulin deficiency | Reduced cellular uptake | Diabetic ketoacidosis |
β-blockers | Reduced intracellular uptake | Non-selective agents |
Excess potassium administration | Increased intake | IV potassium or supplements |
The 10 highest-yield causes of hypokalaemia
Cause | Mechanism | High-yield MRCP clue |
Loop diuretics | Renal potassium loss | Furosemide |
Thiazide diuretics | Renal potassium loss | Hypertension |
Vomiting | Secondary hyperaldosteronism | Metabolic alkalosis |
Diarrhoea | Gastrointestinal loss | Metabolic acidosis |
Hyperaldosteronism | Increased renal secretion | Resistant hypertension |
Insulin therapy | Intracellular shift | DKA treatment |
β2 agonists | Cellular uptake | Salbutamol |
Hypomagnesaemia | Renal potassium wasting | Refractory hypokalaemia |
Cushing syndrome | Mineralocorticoid effect | Hypertension |
Poor dietary intake | Rare alone | Malnutrition, alcoholism |
The five most tested subtopics
1. Drug-induced potassium disorders
The MRCP examination frequently tests medication side effects.
Hyperkalaemia drugs
ACE inhibitors
ARBs
Spironolactone
Eplerenone
Amiloride
Trimethoprim
NSAIDs
Heparin
Tacrolimus
Ciclosporin
Hypokalaemia drugs
Furosemide
Bumetanide
Thiazides
Corticosteroids
Amphotericin B
High-dose penicillins
Salbutamol
Theophylline
Insulin
2. Acid-base disorders
Metabolic acidosis
Usually causes extracellular potassium movement.
Result:
Hyperkalaemia
Important exception:
Diarrhoea causes metabolic acidosis and hypokalaemia because potassium is lost in stool.
Metabolic alkalosis
Encourages intracellular potassium movement.
Result:
Hypokalaemia
Common causes include:
Vomiting
Diuretics
3. Endocrine disorders
Hyperkalaemia
Think:
Addison's disease
Hypoaldosteronism
Hypokalaemia
Think:
Primary hyperaldosteronism (Conn syndrome)
Cushing syndrome
Apparent mineralocorticoid excess
4. Renal causes
Hyperkalaemia commonly results from:
Acute kidney injury
Chronic kidney disease
Type IV renal tubular acidosis
Hypokalaemia commonly results from:
Bartter syndrome
Gitelman syndrome
Renal tubular disorders
Diuretic therapy
5. ECG findings
Every MRCP candidate should recognise these.
Hyperkalaemia
Progression:
Tall peaked T waves
PR prolongation
Loss of P waves
Broad QRS
Sine-wave pattern
Ventricular fibrillation or asystole
Hypokalaemia
Features include:
Flat T waves
ST depression
Prominent U waves
Prolonged QT (apparent)
Ventricular arrhythmias
Practical study list
The following checklist covers the causes most commonly appearing in MRCP questions.
Renal failure
ACE inhibitors
Potassium-sparing diuretics
Addison's disease
Tumour lysis syndrome
Rhabdomyolysis
Diuretics
Vomiting
Diarrhoea
Hyperaldosteronism
β2 agonists
Hypomagnesaemia
If you can explain why each causes potassium abnormalities, you are well prepared for most examination questions.
Practical examples / mini-cases
Mini-case
A 67-year-old man with diabetic nephropathy is started on ramipril. One week later his blood results show:
Potassium: 6.2 mmol/L
Creatinine: increased from baseline
ECG demonstrates peaked T waves.
Question
What is the most likely cause?
A. Excess dietary potassium
B. Addison's disease
C. ACE inhibitor therapy
D. Vomiting
E. Hyperthyroidism
Answer
C. ACE inhibitor therapy
Explanation
ACE inhibitors reduce aldosterone secretion, impairing renal potassium excretion. Patients with chronic kidney disease are particularly susceptible to clinically significant hyperkalaemia.

Practical study-tip checklist
✓ Learn potassium disorders by mechanism, not isolated diseases.
✓ Memorise common drug causes.
✓ Always associate endocrine disease with aldosterone abnormalities.
✓ Never forget hypomagnesaemia as a cause of refractory hypokalaemia.
✓ Revise ECG changes alongside biochemical abnormalities.
✓ Distinguish potassium redistribution from true potassium loss.
✓ Practise interpretation using timed single-best-answer questions.
For additional practice, use the MRCP Part 1 overview:
Strengthen your revision with Free MRCP MCQs:
Watch clinician-led explanations in the MRCP lectures:
Common pitfalls (5 bullets)
Confusing pseudohyperkalaemia with true hyperkalaemia. Haemolysed blood samples, marked thrombocytosis or severe leukocytosis can falsely elevate serum potassium.
Assuming normal serum potassium excludes depletion. Significant total body potassium loss may exist despite a normal blood result.
Forgetting hypomagnesaemia. Potassium replacement often fails until magnesium deficiency is corrected.
Missing drug interactions. ACE inhibitors combined with spironolactone or renal impairment markedly increase hyperkalaemia risk.
Ignoring ECG changes. Treatment urgency depends on both potassium concentration and cardiac manifestations.
FAQs
Why is hyperkalaemia dangerous?
Hyperkalaemia alters cardiac membrane excitability and may rapidly cause fatal arrhythmias. ECG abnormalities warrant urgent assessment and treatment.
Why does insulin lower serum potassium?
Insulin stimulates Na⁺/K⁺-ATPase activity, shifting potassium into cells. This effect is utilised therapeutically in severe hyperkalaemia.
Which drugs are most commonly tested in MRCP potassium questions?
ACE inhibitors, ARBs, spironolactone, amiloride, loop diuretics, thiazides, insulin and β2 agonists are among the highest-yield medications.
Why is hypomagnesaemia associated with hypokalaemia?
Magnesium deficiency increases renal potassium wasting. Potassium replacement alone is frequently ineffective until magnesium is corrected.
How should I revise potassium disorders for MRCP Part 1?
Organise causes into mechanisms—reduced excretion, increased loss, intracellular shifts and endocrine disorders—then reinforce learning with practice questions and ECG interpretation.
Ready to start?
Potassium disorders are among the highest-yield electrolyte topics in MRCP Part 1 and frequently integrate physiology with clinical reasoning. Build confidence by revising the underlying mechanisms rather than memorising isolated lists.
Continue your preparation with:
MRCP Part 1 Overview: https://www.crackmedicine.com/mrcp-part-1/
Free MRCP Question Bank: https://www.crackmedicine.com/qbank/
MRCP Video Lectures: https://www.crackmedicine.com/lectures/
You may also find these related topics useful during revision:
Drug Rashes: SJS vs TEN vs DRESS
Phagocyte Defects: CGD & Chediak-Higashi
Sources
MRCP(UK). https://www.mrcpuk.org/
Kidney Disease: Improving Global Outcomes (KDIGO). https://kdigo.org/
National Institute for Health and Care Excellence (NICE). https://www.nice.org.uk/
European Society of Cardiology Guidelines. https://www.escardio.org/
British National Formulary (BNF). https://bnf.nice.org.uk/




Comments